Evidence map›Paper›PMID 40011677›Full record

ArticleScientific reports2025

Urinary prostaglandin D

Keiko Ishigaki, Atsuko Takeuchi, Mariko Taniguchi-Ikeda, Takatoshi Sato, Terumi Murakami, Minobu Shichiji, Kumiko Ishiguro, Yuki Kihara, Satoru Nagata, Yoshihiro Urade

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Keiko IshigakiDepartment of Pediatrics, School of Medicine, Tokyo Women's Medical University, 8-1, Kawadacho, Shinjuku-ku, Tokyo, 162-8666, Japan. ishigaki.keiko@twmu.ac.jp.
Atsuko TakeuchiKobe Pharmaceutical University, 4-19-1, Motoyama-Kitamachi, Higashinada-ku, Kobe, 658- 8558, Japan.
Mariko Taniguchi-IkedaDepartment of Clinical Genetics, Fujita Health University Hospital, Dengakugakubo, Toyoake, Aichi, Japan.
Takatoshi SatoDepartment of Pediatrics, School of Medicine, Tokyo Women's Medical University, 8-1, Kawadacho, Shinjuku-ku, Tokyo, 162-8666, Japan.
Terumi MurakamiDepartment of Pediatrics, School of Medicine, Tokyo Women's Medical University, 8-1, Kawadacho, Shinjuku-ku, Tokyo, 162-8666, Japan.
Minobu ShichijiDepartment of Pediatrics, School of Medicine, Tokyo Women's Medical University, 8-1, Kawadacho, Shinjuku-ku, Tokyo, 162-8666, Japan.
Kumiko IshiguroDepartment of Pediatrics, School of Medicine, Tokyo Women's Medical University, 8-1, Kawadacho, Shinjuku-ku, Tokyo, 162-8666, Japan.
Yuki KiharaDepartment of Pediatrics, School of Medicine, Tokyo Women's Medical University, 8-1, Kawadacho, Shinjuku-ku, Tokyo, 162-8666, Japan.
Satoru NagataDepartment of Pediatrics, School of Medicine, Tokyo Women's Medical University, 8-1, Kawadacho, Shinjuku-ku, Tokyo, 162-8666, Japan.
Yoshihiro UradeIsotope Science Center, Hirono Satellite, The University of Tokyo, Fukushima, 979-0403, Japan.

Funding

Japan Agency for Medical Research and Development (AMED) 23ek0109611h0002MEXT KAKENHI 23K21430MEXT KAKENHI JP 16K10001SHISEIKAI Scientific Award N/A
6 · The paper itself

Abstract

Treatment approaches are lacking for Fukuyama congenital muscular dystrophy (FCMD), the second most common type of pediatric muscular dystrophy after Duchenne muscular dystrophy (DMD) in the Japanese population. Recent studies demonstrating the involvement of prostaglandin (PG) D

Indexed as

DinoprostoneProstaglandin D2Walker-Warburg SyndromeAdolescentBiomarkersCase-Control StudiesChildChild, PreschoolCreatinineFemaleHumansMaleSeverity of Illness IndexBiomarkersCreatinineDinoprostoneProstaglandin D2Fukuyama congenital muscular dystrophyProstaglandin D2Prostaglandin E2tetranor-PGDMtetranor-PGEM

Identifiers

PMID40011677
PMCPMC11865434

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.